UTHR icon

United Therapeutics

332 hedge funds and large institutions have $4.21B invested in United Therapeutics in 2020 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 121 increasing their positions, 119 reducing their positions, and 58 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less funds holding

Funds holding:

11% less funds holding in top 10

Funds holding in top 10: 98 (-1)

18% less capital invested

Capital invested by funds: $5.11B → $4.21B (-$904M)

24% less first-time investments, than exits

New positions opened: 44 | Existing positions closed: 58

Holders
332
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$12.9M
Puts
$5.86M
Net Calls
Net Calls Change

Top Buyers

1 +$22.5M
2 +$20M
3 +$17.3M
4
Ensign Peak Advisors
Ensign Peak Advisors
Utah
+$17M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$16.1M

Top Sellers

1 -$42.4M
2 -$25.3M
3 -$21.8M
4
Two Sigma Investments
Two Sigma Investments
New York
-$18.1M
5
FLAM
First Light Asset Management
Minnesota
-$15.5M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$43M
27
$40.9M
28
$38.5M
29
$35.6M
30
$34.6M
31
$34M
32
$33.9M
33
$32.4M
34
$31.3M
35
$25.8M
36
$24.9M
37
$24.7M
38
$24.3M
39
$23.4M
40
$21.7M
41
$21.3M
42
$20.3M
43
$20.3M
44
$19.5M
45
$17.6M
46
$17.2M
47
$17.2M
48
$16.2M
49
$16.2M
50
$15.8M